Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Optrex Double Action
- Development stage
- Unknown
- Lead developer
- COC Farmaceutici
- Administration
- Ophthalmic
01
Overview
Optrex Double Action Soothing and Lubricating Drops is a medical device designed to alleviate symptoms of allergic conjunctivitis and dry eye disease, such as itching, dryness, irritation, burning sensation, and visual disturbance. It is an ophthalmic formulation that utilizes Carbomer, a water-soluble polymeric resin, to provide prolonged ocular residence time, viscoelastic, and mucoadhesive properties, thereby supplementing the mucin layer of the eye.
- Brand names
- Optrex Double ActionOptrex Double Action Soothing and Lubricating Drops
Beyond the preview
Go deeper on Optrex Double Action.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Optrex Double Action.